NCT00373347 2026-04-17
Identification of New Serum Diagnostic Markers of Hepatocellular Carcinoma
Stanford University
Completed
Clinical Trials
15 trialsNCT07192172 2026-04-13
ERFA
Seoul National University Hospital
Phase NA Completed
NCT04620538 2026-03-30
VOCAL
Imperial College London
Completed
NCT05411133 2026-03-19
Treatment of Cabotamig (ARB202) in Advanced Gastrointestinal Cancer Patients
Arbele Limited
Phase 1 Completed
NCT05359861 2026-03-18
Trial of Atezolizumab and Bevacizumab With SRF388 or Placebo in Patients With Hepatocellular Carcinoma
Coherus Oncology, Inc.
Phase 2 Completed
NCT01165346 2026-03-13
CKNO-HEP
Centre Oscar Lambret
Phase 2 Completed
NCT03151213 2026-03-13
pregabalin
Tanta University
Phase 4 Completed
NCT07224737 2026-03-13
EXOMIC
City of Hope Medical Center
Completed
NCT07225452 2026-03-13
LUMIC
City of Hope Medical Center
Completed
NCT07407257 2026-02-18
SBRT for Liver Tumors, Liver Metastases, and Pancreatic Tumors
Institute of Oncology Ljubljana
Phase NA Completed
NCT04288323 2026-02-12
Gadolinium Contrast-enhanced Abbreviated MRI (AMRI) vs. Standard Ultrasound for Hepatocellular Carcinoma (HCC) Surveillance in Patients With Cirrhosis
University of California, San Diego
Phase 4 Completed
NCT06229080 2026-02-12
SEGWAY
Next Biomedical Co., Ltd.
Phase NA Completed
NCT03256994 2026-02-05
CIRT-FR
Cardiovascular and Interventional Radiological Society of Europe
Completed
NCT07386639 2026-02-04
GENDER-HCC-MET
Tongji University
Completed
NCT04341012 2026-01-26
Breath Analysis Based Disease Biomarkers
Mayo Clinic
Completed